Health Science Reports · Nov 11, 2026

Artificial Intelligence for Early Cancer Detection in Nigeria: A Contextual Narrative Review of Applications, Barriers, and Implementation Pathways

By Gopep NS, Oduoye MO, Akhtar Z et al.

Background and Aims: Cancer remains a major public health challenge in Nigeria, with late‐stage diagnosis driving high mortality. While artificial intelligence (AI) has demonstrated strong diagnostic performance globally, its role in Nigeria's oncology landscape is poorly defined. This review synthesizes current evidence on AI applications for early cancer detection in Nigeria, critically evaluates methodological and infrastructural barriers, and proposes context‐specific implementation pathways. Methods: A narrative review was conducted using PubMed, Web of Science, Google Scholar, and African Journals Online to identify literature published from 2014 to 2024. Results: Sixty studies met the inclusion criteria, of which 15 were Nigeria‐led. AI models achieved high diagnostic accuracy in breast (91%–98%), cervical (92%–96%), and prostate cancers (Area Under the Curve: 0.93–0.97). Smartphone‐based AI pilots in Lagos and Ibadan demonstrated feasibility in low‐resource settings. However, methodological heterogeneity, limited local datasets, and the absence of standardized benchmarks constrain generalizability. Key barriers include unreliable electricity, poor broadband, workforce shortages, and weak regulatory frameworks. Conclusion: AI offers transformative potential for early cancer detection in Nigeria, but success requires staged implementation: short‐term pilots in teaching hospitals, medium‐term development of national AI guidelines and workforce training, and long‐term integration into cancer control plans. Investment in local data repositories, renewable‐energy‐powered diagnostic centers, and structured public–private partnerships is essential to reduce diagnostic delays and mortality.

doi.org/10.1002/hsr2.73512Open accessPubMed 43022506Biomarkers

AgingResearch.News